A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia

Clinical trial NCT05458128 · COMPLETED

Trial details

NCT number: NCT05458128
Sponsor: Harmony Biosciences Management, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Hypersomnia Excessive Daytime Sleepiness

Start date: 2022-08-19
Primary completion: 2025-10-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.